Möchten Sie immer auf dem neuesten Stand bleiben?

NEW YORK and MIAMI, March 04, 2026 (GLOBE NEWSWIRE) -- House of Doge, the official corporate arm of the Dogecoin Foundation, along with merger partner Brag House Holdings (NASDAQ:TBH) and partner...

SINGAPORE, March 04, 2026 (GLOBE NEWSWIRE) -- FAST TRACK GROUP (NASDAQ: FTRK) ("Fast Track" or the "Company"), a leading entertainment-focused event management and celebrity agency company,...

~ Pre-Recorded Investor Call Now Available; Presentation Previously Filed with the SEC ~ ~ $500 Million Pipeline and $71 Million Backlog Highlight Strong Business Momentum ~ ~ Combined Company to Be...

HINGHAM, Mass., March 04, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, commends the American...

NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Fluent, Inc. (NASDAQ: FLNT), a leading commerce media solutions provider, today announced that Don Patrick, Chief Executive Officer, and Ryan Perfit,...

Clover Health Moves from Pledge to Production, Becomes The First Payer Live on a CMS Aligned Network

TORRANCE, Calif. and LAUSANNE, Switzerland, March 04, 2026 (GLOBE NEWSWIRE) -- Navitas Semiconductor (Nasdaq: NVTS), a leader in GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC)...

Three Sites Now Live as Blink Advances EV Charging Rollout of 220 Planned Charging Ports Across 90 Korian Locations Throughout Belgium Antwerp, BELGIUM, March 04, 2026 (GLOBE NEWSWIRE) -- Korian...

Phase 3 study designed with total hip BMD primary endpoint assessed at 12 months, rather than at 24 months EB613 single tablet final commercial formulation (Next-Gen EB613) replaces multi-tablet...

Enrollment for the OCU400 Phase 3 liMeliGhT clinical trial—the first and largest gene therapy registrational trial for broad retinitis pigmentosa patients—was completed. Topline Phase 3 data expected...